萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Mehdi S Mirsaeidi, MD, MPH

Pulmonologist, Critical Care Medicine Physician

4.9 /5 158 ratings

Additional languages:: Persian

Request appointment online

Research at a glance

Top areas of exploration

Mycobacterium tuberculosis , 21 publications
Antitubercular Agents , 20 publications
COVID-19 , 18 publications
Tuberculosis, Pulmonary , 15 publications

Research activity

241 publications

9,084 citations

Why is this important?

Active clinical trials

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis

Investigator: Mehdi S Mirsaeidi
Status: Accepting Candidates
Ages: 18 Years - 75 Years
Sexes: All

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial

Investigator: Mehdi S Mirsaeidi
Status: Accepting Candidates
Ages: 30 Years - NA Years
Sexes: All

A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection

Investigator: Mehdi S Mirsaeidi
Status: Accepting Candidates
Ages: 18 Years - 85 Years
Sexes: All

My publications

241 publications

2022

Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2.

Frontiers in medicine

鈥�

2022

Anti-inflammatory Properties of the Alpha-Melanocyte-Stimulating Hormone in Models of Granulomatous Inflammation.

Lung

鈥�

2022

Editorial: Sarcoidosis-The great mimicker.

Frontiers in medicine

鈥�

2022

Health effects of radioactive contaminated dust in the aftermath of potential nuclear accident in Ukraine.

Frontiers in public health

鈥�

2022

Pericardial Epithelioid Inflammatory Myofibroblastic Sarcoma: An Atypical Presentation.

Cureus

鈥�